Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
suspected allergic reaction; "hives, swelling, rash, itching".; "hives, swelling, rash, itching".; "hives, swelling, rash, itching".; "hives, swelling, rash, itching".; This spontaneous report was received from a registered nurse and refers to 1 year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included Eczema, and Drug Reactions/Allergies to tetanus toxoid. Historical drugs included Tetanus toxoid (Tetanus vaccine toxoid). Concomitant therapies were not reported. On 20-MAY-1996, the patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) solution for injection as prophylaxis (exact formulation, dose, route and anatomical location of administration, lot number and expiration date were not provided) reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (formulation, lot number and expiration date not provided). On an unknown date in 1996, had a reaction which was described as "hives, swelling, rash, itching". Patient has not had their second dose due to the suspected allergic reaction (drug hypersensitivity). The outcome of the events was reported as recovered. The causality assessment between the events and the suspect vaccine was considered to be related.
Allergy to vaccine; Eczema
sterile diluent